Dr. Giselle Maria Petzinger, MD

Dr. Petzinger practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Petzinger's NPI, 1003857715, was assigned on June 10, 2006. Dr. Petzinger graduated from Keck School of Medicine of USC in 1988. Dr. Petzinger's California license number on file is G81976.

Dr. Petzinger's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Petzinger's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Petzinger is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Petzinger to 1 more hospital, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petzinger practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Petzinger's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Petzinger is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Petzinger's licenses on file in 3 states: California, New York and Connecticut.

Dmand AI lists essential tremor, fibromyalgia and chronic pain, lower back pain, non-alzheimer's dementia (chronic), parkinson's disease, restless legs syndrome and thoracic spine disorders among the conditions Dr. Petzinger treats.

CMS data shows 488 Medicare services from Dr. Petzinger across 3 procedure codes in 2024, all of them office visits, for 231 Medicare patients. Medicare paid $39,208 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Dr. Petzinger in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high cholesterol, and 75% have parkinson's disease. 29% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Petzinger's median patient age at 74, with 54% women.

In 2024, Dr. Petzinger wrote 2,800 Medicare Part D claims for 234 patients. 89% of them were for generic drugs. CMS names the drug for 2,685 of them, across 36 drugs with 11 or more claims each, at $693,492 in total drug cost. In 2023, CMS named 2,777 claims across 37 drugs.

Dr. Petzinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Petzinger as offering telehealth.

Dmand AI links 14 papers to Dr. Petzinger, published from 2010 to 2021. 2010 was the busiest year, with 3. Dr. Petzinger's most frequent co-authors are Daniel Holschneider, MD, Jennifer Shiaolin Hui, MD and Eleni Antzoulatos.

Dmand AI links Dr. Petzinger to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 10 general payments to Dr. Petzinger from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. ACADIA Pharmaceuticals Inc paid the most, $325.

Dr. Petzinger graduated from Keck School of Medicine of USC in 1988.

Dr. Petzinger is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.